Successful participation at the Healthtech Innovation Days in Paris - representatives from the STERN BioRegion impress
The Healthtech Innovation Days (HTID #6), a central European event for healthcare innovation, took place in Paris on 17 and 18 September. Around 400 participants, including scientific players and investors, took part.
The event was organised by HealthTech For Care, which serves as a platform for the exchange of ideas and innovations in the healthcare sector. BioRegio STERN Management GmbH was also on site and supported start-ups from the region. The companies MIRA vision microscopy (represented by Leonid Mill), FlareOn Biotech (represented by Anna Herrmann) and asetreat (represented by Inga Hagen) had the opportunity to pitch their innovative projects.
Particularly noteworthy is the success of Leonid Mill and Lukas M. Mürdter, who took 2nd place in the HTID #6 Pitch Competition with their startup MIRA vision microscopy. Congratulations to them!
Leonid Mill receives the prize for 2nd place in the HTID #6 Pitch Competition
/ Copyright: HealthTech For CareThe start-ups from the STERN BioRegion
asetreat – Innovative technology for wound healing
With its ecure® product, asetreat is revolutionising wound care with an innovative bioelectric wound dressing that activates the body's natural healing processes. This technology promotes cell migration and accelerates the healing of chronic and complex wounds. The wound dressing is characterised by simple handling, requires no external energy sources and can also be used by untrained personnel in home care. This reduces visits to the doctor, lowers treatment costs and minimises patient suffering.
MIRA vision microscopy – Precision medicine with artificial intelligence
MIRA vision microscopy is setting new standards in the laboratory market by making diagnostics and drug development more efficient and cost-effective. The aim is to improve accessibility in human and veterinary medicine, pharmacy and industry. Using a patented AI technology, the speed and accuracy of analysis is optimised, leading to faster and more effective treatments. The company offers a wide range of microscopic analyses in biomedicine and delivers precise, reliable results that are crucial for the diagnosis and treatment of diseases.
Fast tool for tumour margin assessment: FlareOn Biotech optimises HNSCC resections
FlareOn Biotech offers a new, rapid tool for assessing tumour margins in head and neck squamous cell carcinoma (HNSCC) directly in the operating theatre. The patented sensor reacts to active proteases in excised tumour tissue and helps surgeons make critical decisions to ensure complete cancer removal. This fluorescence-based approach improves accuracy and shortens surgical time, minimising the need for lengthy histopathological analysis. FlareOn Biotech enables faster and more precise tumour resections, improving patient outcomes while streamlining the surgical process.
BioRegio STERN Management GmbH